Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
Merck(MRK) stock is priced at $112.45, giving the company a market capitalization of 277.36B. It carries a P/E multiple of 31.96 and pays a dividend yield of 2.9%.
On 2026-05-07, Merck(MRK) stock moved within a range of $111.10 to $113.75. With shares now at $112.45, the stock is trading +1.2% above its intraday low and -1.1% below the session's peak.
Trading volume for Merck(MRK) stock has reached 6.81M, versus its average volume of 9.19M.
The stock's 52-week range extends from a low of $73.31 to a high of $125.14.
The stock's 52-week range extends from a low of $73.31 to a high of $125.14.
MRK News
Merck (NYSE:MRK) has closed its acquisition of Terns Pharmaceuticals, adding TERN-701, a chronic myeloid leukemia drug with FDA Breakthrough Therapy Designation...
Citi analyst Geoff Meacham reinstated coverage of Merck (MRK) with a Neutral rating and $125 price target Citi views the company’s Q1 report as solid but wants...
This article examines whether Merck, at around US$113 per share, still offers value or if most of the upside is already reflected in the price, by breaking down...
Analyst ratings
67%
of 30 ratingsMore MRK News
Merck (MRK) announced the completion of the acquisition of Terns Pharmaceuticals (TERN). TERN-701 was recently granted Breakthrough Therapy Designation by the U...
Warren Buffett Owns 2 of the Small Dogs of the Dow: Here’s Why You Need to Own All 5 By Lee Jackson Published May 4, 7:44AM EDT Quick Read Both the Nasdaq and...
Merck (MRK) moved after first quarter results topped expectations, with strength in Keytruda, animal health, and new launches such as WINREVAIR and IDVYNSO supp...
In late April 2026, Merck reported stronger-than-expected first-quarter results, raised its full-year revenue and earnings guidance, and secured FDA approval fo...
Technology Merck's Biggest Looming Rival In Cancer Just Took A Gut Punch Licensing Summit Therapeutics (SMMT) stock crashed Friday after the company said its ex...
Merck & Company ((MRK)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and powe...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.